Yttrium-90

CEA cell adhesion molecule 3 ; Homo sapiens







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31910346 Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies. 2020 Feb 2
2 19351765 A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignancies. 2009 Apr 15 7
3 18256832 Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects. 2008 Aug 1
4 11051230 A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies. 2000 Oct 3
5 8436526 Comparison of radioimmunotherapy and external beam radiotherapy in colon cancer xenografts. 1993 Feb 15 1
6 3675197 Therapy of peritoneal carcinomatosis of human colon cancer xenografts with yttrium 90-labeled anti-carcinoembryonic antigen antibody ZCE025. 1987 Nov 1